Projects per year
Organisation profile
Organisation profile
The NORLUX Neuro-Oncology laboratory was set up through a collaborative agreement between LIH and the University of Bergen in Norway based on an extensive collaboration with Prof. Rolf Bjerkvig from the Department of Biomedicine at the University of Bergen. The mission of our lab is to improve the life and prognosis of people affected by a malignant brain tumor.
We aim to improve the treatment options for malignant brain tumors, with a focus on diffuse gliomas. With a radically translational approach to research, we work with patient samples and innovative patient-derived preclinical model systems that recapitulate the patient tumor. Our research investigates the cellular and molecular basis of gliomas, their capacity to invade the normal brain and escape therapy. Special areas of interests are tumor plasticity, tumor heterogeneity, tumor metabolism, immuno-oncology and pharmacogenomics.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
PERSIST: Role of glioblastoma persister cells in shaping immune microenvironment and resistance to treatment
Golebiewska, A. (PI), Nazarov, P. (CoPI) & Triballier, G. (PhD Student)
1/10/25 → 30/09/27
Project: Research
-
MITOFIT: The importance of being MitoFit: targeting mitochondrial metabolism in glioblastoma multiforme
Golebiewska, A. (PI), Meiser, J. (CoPI) & Griffith, C. (Partner)
FNR - Fonds National de la Recherche
1/03/24 → 31/05/27
Project: Research
-
CANBIO2 (Hamed Allahverdi): Tumour plasticity as a treatment resistance mechanism in glioblastoma.
Golebiewska, A. (PI) & Allahverdi, H. (PhD Student)
FNR - Fonds National de la Recherche
1/12/23 → 30/11/27
Project: Research
-
Acquired genetic and cell-state changes in IDH-mutant glioma progression
Johnson, K. C., Spitzer, A., Varn, F. S., Nomura, M., Garofano, L., Chowdhury, T., Lipsa, A., Zhang, L., Fernández, E. C., Barak, T., Gulhan Ercan-Sencicek, A., Peksen, A. B., Anderson, K. J., Tesileanu, C. M. S., Amin, S. B., Kocakavuk, E., Zhao, D., D’Angelo, F., Migliozzi, S. & Bussema, L. & 31 others, , Jul 2026, In: Nature. 655, 8124, p. 1048-1059 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastoma
Lier, S., Markusson, S. B., Kocijancic, A., Narum, M., Lund, S. O., Böllering, B., Lipsa, A., Søegaard, M. L. C., Rein, I. D., Santha, P., Jain, P., Lång, A., Lång, E., Meyer, N., Dutta, A., Anand, S., Badugu, S. B., Nesse, G. J., Forstrøm, R. J. & Klungland, A. & 10 others, , May 2026, In: EMBO Molecular Medicine. 18, 5, p. 1592-1624 33 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
Circulating immune profiling reveals impaired monocyte states and trajectories driving immunosuppression in glioblastoma
Scafidi, A., Kaoma, T., Cerella, C., Campus, E., Grzyb, K., Nosirov, B., Lind-Holm Mogensen, F., Klein, E., Da Costa, R., Skupin, A., Hertel, F., Berchem, G., Mittelbronn, M., Cosma, A., Melin, B., Niclou, S. P., Nazarov, P. V., Golebiewska, A., Poli, A. & Michelucci, A., 16 Jul 2026, In: Journal of Neuroinflammation . 23, 1, 306.Research output: Contribution to journal › Article › Research › peer-review
Open Access